RESULTS OF CONTROLLED TRIALS OF EXPERIMEN TAL RECOMBINANT LIVE VACCINE AGAINST HEPATITIS-B

Authors
IKOYEV VN GORBUNOV MA BEKTIMIROV TA NOSKOVA AV PEREKREST VV
Citation
Vn. Ikoyev et al., RESULTS OF CONTROLLED TRIALS OF EXPERIMEN TAL RECOMBINANT LIVE VACCINE AGAINST HEPATITIS-B, Voprosy virusologii, 42(3), 1997, pp. 135-137
Citations number
11
Categorie Soggetti
Virology
Journal title
Voprosy virusologii → ACNP
ISSN journal
05074088
Volume
42
Issue
3
Year of publication
1997
Pages
135 - 137
Database
ISI
SICI code
0507-4088(1997)42:3<135:ROCTOE>2.0.ZU;2-1
Abstract
Experimental recombinant vaccine against hepatitis B Revacc B based on vaccinia virus has been tried. The preparation was weakly reactogenic bur did not induce the production of anti-HBsAg antibodies. On the ot her hand, recombinant vaccine against hepatitis B Engerix B, used in a blind experiment as the agent of comparison, induced the production o f anti-HBs in 91% of vaccinees.